Review Article
Volume 7 Issue 1 - 2020
Contrast Induced Nephropathy in Cardiology, Prevention and Treatment: A Systematic Review
Rubino M, Di Caccamo L, Luparelli M, Bonni E, Trovato OC, Evola S, Buccheri D and Dario Buccheri*
Interventional Cardiology, S. Antonio Abate Hospital, Trapani, Italy
*Corresponding Author: Dario Buccheri, Interventional Cardiology, S. Antonio Abate Hospital, Trapani, Italy.
Received: December 09, 2019; Published: December 27, 2019




Abstract

Contrast induced Nephropathy (CIN) is a serious complication of all angiographic procedures, caused by the use of an iodinated contrast media (CM). CM is a substance able to induce a transient and self-limited acute kidney injury (AKI). CIN is the third common cause of AKI and represent the 12% of AKI developed in hospital. Nowadays there is not a treatment for CIN, the only therapeutic strategy is prevention.

Keywords: Contrast Induced; Nephropathy

References

  1. Nazar MA Mohammed., et al. “Contrast-induced Nephropathy”. Heart Views 14 (2013): 106-116.
  2. SD Weisbord., et al. “Incidence and outcomes of contrast-induced AKI following computed tomography”. Clinical Journal of the American Society of Nephrology 3.5 (2008): 1274-1281.
  3. R Solomon and HL Dauerman. “Contrast-induced acute kidney injury”. Circulation 122.23 (2010): 2451-2455.
  4. Felix G Meinel., et al. “Contrast-Induced Acute Kidney Injury: Definition, Epidemiology, and Outcome”. BioMed Research International (2014): 6.
  5. Katholi RE., et al. “Oxygen free radicals and contrast nephropathy”. American Journal of Kidney Diseases 32 (1998): 64‑71.
  6. Romano G., et al. “Contrast agents and renal cell apoptosis”. European Heart Journal 29 (2008): 2569‑2576.
  7. “The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) 2018 ESC guidelines on myocardial revascularization”. European Heart Journal 40 (2019): 87-165.
  8. Cigarroa RG., et al. “Dosing of contrast material to prevent contrast nephropathy in patients with renal disease”. The American Journal of Medicine 86 (1989): 649-652.
  9. Joe Aoun., et al. “Allowable Contrast Dose and Prevention of Acute Kidney Injury Following Cardiovascular Procedures”. Current Opinion in Nephrology and Hypertension 27.2 (2018): 121-129.
  10. Aaron M From., et al. “Iodixanol versus Low osmolar Contrast Media for prevention of Contrast- induced Nephropathy et al. Contrast-induced Nephropathy”. Circulation 3 (2010): 351-358.
  11. Mager A., et al. “The ratio of contrast volume to glomerular filtration rate predicts outcomes after per- cutaneous coronary intervention for ST-segment elevation acute myocardial infarction”. Catheterization and Cardiovascular Interventions 78 (2010): 198-201.
  12. Laskey WK., et al. “Volume-to-creatinine clearance ratio: A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention”. Journal of the American College of Cardiology 50 (2007): 584-590.
  13. Mehran R., et al. “A simple risk score for prediction of contrast-induced nephropathy after precutaneous coronary intervention. Development and initial validation”. Journal of the American College of Cardiology 44 (2004):1393-1399. 
  14. Coca SG., et al. “The prognostic importance of a small decrement in kidney function in hospitalized patients. A sistematic review and meta-analysis”. American Journal of Kidney Diseases 50 (2007): 712-720.
  15. Hoste EA., et al. “Sodium bicarbonate for prevention of contrast‑induced acute kidney injury: A systematic review and meta‑analysis”. Nephrology Dialysis Transplantation 25 (2010): 747‑758.
  16. Briguori C., et al. “Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies”. Circulation 115 (2007): 1211‑1217.
  17. Zoungas S., et al. “Systematic review: Sodium bicarbonate treatment regimens for the prevention of contrast‑induced nephropathy”. Annals of Internal Medicine 151 (2009): 631‑638.
  18. From AM., et al. “Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at mayo clinic”. Clinical Journal of the American Society of Nephrology 3 (2008): 10‑18.
  19. Merten GJ., et al. “Prevention of contrast‑induced nephropathy with sodium bicarbonate: A randomized controlled trial”. Journal of the American Medical Association 291 (2004): 2328‑2334.
  20. Drager LF., et al. “Renal effects of N‑acetylcysteine in patients at risk for contrast nephropathy: Decrease in oxidant stress‑mediated renal tubular injury”. Nephrology Dialysis Transplantation 19 (2004): 1803‑1807.
  21. ACT Investigators. “Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)”. Circulation 124 (2010): 1250-1259.
  22. Quintavalle C., et al. “Impact of a high loading dose of atorvastatin on contrast‑induced acute kidney injury”. Circulation 126 (2012): 3008‑3016.
  23. Khanal S., et al. “Statin therapy reduces contrast‑induced nephropathy: An analysis of contemporary percutaneous interventions”. The American Journal of Medicine 118 (2005): 843‑849.
  24. Li H., et al. “Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis”. American Journal of Cardiovascular Drugs 16 (2016): 201-219.
  25. Zhang T., et al. “Statins for the prevention of contrast induced nephropathy: A systematic review and meta‑analysis”. American Journal of Nephrology 33 (2011): 344‑3451.
  26. Giacoppo D., et al. “Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients”. Circulation: Cardiovascular Interventions 10 (2017): e004383.
  27. Mueller C. “Prevention of contrast‑induced nephropathy with volume supplementation”. Kidney International (2006): S16‑S19. 
  28. Weisbord SD and Palevsky PM. “Prevention of contrast‑induced nephropathy with volume expansion”. Clinical Journal of the American Society of Nephrology 3 (2008): 273‑280.
  29. Brar SS., et al. “Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial”. Lancet 31 (2011): 2501-2555.
  30. Maioli M., et al. “Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial”. Circulation: Cardiovascular Interventions 4 (2011): 456-462.
  31. Stevens MA., et al. “A Prospective Randomized Trial of Prevention Measures in Patients at High Risk for Contrast Nephropathy Results of the P.R.I.N.C.E. Study”. Journal of the American College of Cardiology 33 (1999): 403-411.
  32. Mattathil S., et al. “Use of the RenalGuard system to prevent contrast-induced AKI: A meta-analysis”. Journal of Interventional Cardiac 30 (2017): 480-487.
  33. Briguori C., et al. “Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II) RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury”. Circulation 124 (2011): 1260-1269.
Citation: Dario Buccheri., et al. “Contrast Induced Nephropathy in Cardiology, Prevention and Treatment: A Systematic Review”. EC Cardiology 7.1 (2020): 01-12.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


June Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the June issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before June 30, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk